As of Jun 22
| +0.42 / +4.68%|
The 2 analysts offering 12-month price forecasts for Arcturus Therapeutics Ltd have a median target of 21.00, with a high estimate of 22.00 and a low estimate of 20.00. The median estimate represents a +123.40% increase from the last price of 9.40.
The current consensus among 2 polled investment analysts is to Buy stock in Arcturus Therapeutics Ltd. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.